Vaccine research organizations recently announced a new program in Kenya, Rwanda, and the Democratic Republic of Congo to evaluate the safety and immunogenicity of homologous and heterologous COVID-19 vaccine booster regimens in people living with Human immunodeficiency virus (HIV).
The Coalition for Epidemic Preparedness Innovations (CEPI) and the Kenya-based Victoria Biomedical Research Institute (VIBRI) confirmed on May 11, 2022, that about $12.5 million in funding would be deployed to assess this “mix and match” booster approach in HIV populations.
Do HIV and COVID-19 Vaccines Mix?
Previous Myocardial Injury Tied to Worse COVID-19 Outcomes
Significant but weaker associations with selected adverse outcomes seen for preexisting hypertension, diabetes, and ischemic heart disease
‘Tragic Milestone’: One Million American Lives Lost to COVID-19
President Biden has ordered U.S. flags to be flown at half-staff in honor of those lost
Health Improves Over Two Years for COVID-19 Hospitalization Survivors
Improvements seen in physical and mental health, but survivors still have more symptoms than controls at two years
2019 to 2020 Saw Increase in Overall Firearm Homicide Rates
Largest increases seen among non-Hispanic Black males aged 10 to 44 years and in American Indian, Alaska Native males aged 25 to 44 years
Self-Reported Postpartum Depressive Symptoms Up During Pandemic
States with greater increases in symptoms had fewer deaths from COVID-19 and lower women’s unemployment rates
Recent Cancer Treatment Linked to Worse COVID-19 Outcomes
However, a history of cancer more than one year before COVID-19 diagnosis not tied to increased mortality or hospitalization
Neuropsychiatric Sequelae Similar for Severe COVID-19, SARI
Neuropsychiatric sequelae are comparable for survivors of COVID-19 hospitalization, other severe acute respiratory infections
Lack of Asthma Control More Likely With COVID-19-Related Anxiety
Second study shows most parents of children with food allergy report unchanged or decreased food allergy-specific anxiety during pandemic
Company Hid Problems With COVID-19 Vaccines From FDA
Nearly 400 million doses of vaccine made by Emergent had to be destroyed ‘due to poor quality control’